Clinical Expertise at Aspire for Wellness Together
Aspire for Wellness Together is led by Sandra Mannon, DNP, APRN , a family nurse practitioner whose healthcare career began in 1992. Her clinical background includes 20 years in critical care, followed by advanced practice nursing and functional medicine. Dr. Mannon also has extensive experience in healthcare education, including 10 years as adjunct faculty teaching senior nurse practitioner students. Her approach emphasizes individualized care, patient education, and long-term health and wellness.
Most advice about botox injections under eyes starts with the promise of a quick way to soften fine lines. That framing is incomplete. The lower eyelid is a small, mobile structure positioned close to the muscles and tear-producing system that protect the eye, so a treatment that looks minor can create functional problems when the indication, dose, or placement is wrong.
The right question isn't whether Botox can reduce movement-related lines. It's whether the lines come from muscle activity, whether the eyelid can tolerate additional weakening, and whether the expected cosmetic improvement justifies possible changes in blinking, tear-film stability, or lower-lid position. A careful consultation should answer those questions before anyone reaches for a syringe.
Table of Contents
- The Hidden Risks of Under-Eye Botox
- Anatomy and Safety Constraints
- Clinical Technique and Dosing
- Comparing Botox to Fillers and Surgery
- Patient Selection and Contraindications
- Managing Expectations and Recovery
The Hidden Risks of Under-Eye Botox
Clinically, under-eye Botox belongs to a high-consequence anatomical zone. The lower eyelid sits beside the orbicularis oculi, which helps close the eye and supports normal blinking, as well as structures involved in tear distribution and drainage. A small treatment area can therefore carry functional consequences beyond wrinkle reduction.
Botulinum toxin softens dynamic lines by reducing muscle contraction. Excessive weakening or unintended spread may disturb eyelid closure, tear-film stability, or lower-lid position. Recognized periorbital complications include eyelid droop, ectropion, dry eye, lagophthalmos, and pseudoherniation of infraorbital fat pads. Blepharoptosis has been estimated at 1% to 5% overall in glabellar treatment and reported as high as 2% to 20% in some forehead injection series, according to this clinical review of botulinum toxin complications.
The functional trade-off
A weaker orbicularis oculi can change more than the appearance of a crease. Incomplete blinking may spread tears unevenly across the cornea, leading to irritation, fluctuating vision, or a gritty sensation. The FDA labeling warns that reduced blinking after injections in or near this muscle can cause corneal exposure, a persistent corneal epithelial defect, and corneal ulceration, particularly in people with facial nerve disorders. It also advises patients to report eye dryness, which may require drops, ointment, contact lenses, or patching. These warnings appear in the FDA BOTOX Cosmetic safety labeling.
Practical rule: A subtle wrinkle benefit isn't a good result if the patient leaves with worse blinking or uncomfortable eyes.
Contact-lens use, pre-existing dry eye, and lower-lid laxity can reduce the safety margin. None automatically rules out treatment, but each warrants a careful assessment. Examine the eyelid at rest and during blinking. A small dose does not make an unsuitable eyelid low risk.
A 2025 lower-eyelid clinical series treated 42 patients, with 1 case of pseudo-eyebag observed. The authors also noted possible eyelid laxity, pseudo-bags, muscle dysfunction, and diplopia. A favorable series therefore does not make the procedure risk-free. Treatment planning should account for the patient's baseline blink, tear symptoms, and lid support before cosmetic benefit is pursued.
For broader background, review Botox injection risks before scheduling treatment.
Anatomy and Safety Constraints
Safe treatment begins with anatomy, not a standard dot pattern. The orbicularis oculi surrounds the eye in portions commonly described as pretarsal, preseptal, and orbital. These portions overlap in function but differ in their relationship to the eyelid, orbital septum, and surrounding soft tissue.
The pretarsal portion lies closest to the tarsal plates and contributes to gentle eyelid closure. The preseptal portion sits anterior to the orbital septum and participates in blinking and eyelid movement. The orbital portion extends farther around the orbit and contributes to forceful closure and facial expression. Weakening the wrong fibers can affect eyelid tone or the normal pumping action that helps move tears across the ocular surface.
Why diffusion matters
The orbital septum is thin, and the levator palpebrae superioris lies close enough that unintended diffusion can affect eyelid elevation. A clinical review reports an average ptosis incidence of 6.5% in published reports and recommends staying superior to the Frankfort line, avoiding overdilution, and limiting total units in the region. Its periorbital injection safety guidance illustrates why dilution, volume, depth, and location all matter.
The lower lid also depends on the lateral canthal tendon and adjacent supporting tissues for position. If those structures are already stretched or weak, reducing orbicularis activity may make the lid look less supported. The result can include increased scleral show, outward turning of the lid, or poorer contact between the lid and the eye.
Muscle isn't the same as volume
Botox treats movement. It does not replace lost volume, reposition a protruding fat pad, tighten excess skin, or remove a tear trough. A hollow under-eye may remain hollow after the muscle relaxes, and a pseudo-bag may look more obvious if the surrounding muscle no longer provides the same tension.
Tear-film physiology is another reason to avoid casual treatment. Objective testing after lateral canthal botulinum toxin A found that tear-film stability decreased as early as 1 week and remained reduced for more than 3 months, while tear production reached its lowest point at 1 month before gradually recovering, as reported in this tear-film study. Those effects demonstrate that periocular injections can influence ocular function over time, even when the injection is not placed directly beneath the eye.
Clinical Technique and Dosing
Lower-eyelid injections require a clinician who can distinguish a true dynamic wrinkle from laxity, hollowing, swelling, or fat prominence. The treatment plan should be based on examination, facial movement, eyelid support, ocular history, and the desired degree of muscle relaxation. There isn't a universally safe formula for every face.
What the assessment should include
A practitioner should inspect the lower lid while the patient is relaxed, blinking, smiling, and squeezing the eyes shut. Snap-back and lid-distraction assessments help identify laxity, while questions about dryness, contact lenses, prior eyelid surgery, facial nerve problems, and current medications reveal factors that may change candidacy.
Skin preparation and patient positioning should support control and visualization. A fine needle and conservative placement can reduce unnecessary tissue disruption, but the instrument alone doesn't make a technique safe. The injector must understand the depth of the muscle, the location of the lid margin, and the direction in which product could diffuse.
Dosing isn't a universal recipe
The FDA-approved BOTOX Cosmetic labeling for lateral orbicularis oculi treatment specifies 4 Units per 0.1 mL into 3 sites per side, for a total of 24 Units across both sides, or 12 Units per side. That framework applies to the labeled lateral canthal treatment, not automatically to off-label lower-eyelid injections. The FDA BOTOX Cosmetic prescribing information should be interpreted alongside the patient's anatomy and the approved treatment area.
Lower-eyelid placement is particularly sensitive because a small volume can spread into nearby structures. A clinician may decide that no injection is safer than trying to erase a line that results partly from skin quality or volume loss. Intradermal or very superficial placement, minimal volume, and a conservative total exposure may be considered in selected patients, but exact units and points should be determined by the treating professional rather than copied from an online protocol.
Post-treatment handling matters too. Patients should follow the injector's instructions, avoid rubbing the area, and report new dryness, difficulty closing the eye, vision changes, or an unusual change in eyelid position promptly. To discuss how Botox in Bradenton, FL may fit into a broader facial assessment, schedule an individualized consultation rather than requesting a predetermined dose.
Comparing Botox to Fillers and Surgery
The most common treatment mistake is matching the procedure to the trend instead of the anatomy. Botox is suited to movement-related lines. Dermal fillers address selected volume deficits, while lower blepharoplasty is designed for structural concerns such as excess skin or prominent fat. These options may overlap in a full rejuvenation plan, but they don't solve the same problem.
| Parameter | Botox | Dermal Fillers | Lower Blepharoplasty |
|---|---|---|---|
| Primary indication | Dynamic lines caused by muscle activity | Selected hollows and volume deficits | Excess skin or herniated fat requiring structural correction |
| How it works | Temporarily reduces targeted muscle contraction | Adds volume beneath the skin | Removes or repositions tissue through surgery |
| Duration | Effects commonly require maintenance, and published consumer guidance often describes a temporary course | Longevity varies by product, placement, and patient factors | Often provides longer-lasting structural change |
| Downtime | Usually limited, but eye-related symptoms can require medical attention | Swelling and bruising are possible, with vascular complications requiring urgent evaluation | Involves incisions, anesthesia considerations, and a more involved recovery |
| Best fit | Mild to moderate dynamic creasing in a suitable eyelid | Hollowing when the patient has adequate lid support and appropriate anatomy | Skin excess, fat prominence, or laxity that injectables can't correct |
| Main limitation | Doesn't replace volume or tighten skin | Can worsen puffiness or look inappropriate in compromised anatomy | More invasive and not appropriate for every medical history |
Choosing the tool for the problem
If a line appears mainly when you smile or squint and disappears at rest, reducing muscle activity may help. If a shadow remains visible with the face relaxed because of hollowing, Botox won't fill it. If the concern is a bulge from fat or loose skin, weakening the surrounding muscle can fail to improve the issue and may make the lower lid look less supported.
Fillers carry their own risks, including vascular occlusion and a visible bluish discoloration when product is placed too superficially. Lower-lid surgery carries the risks associated with an operation, including anesthesia, incisions, swelling, and recovery. That doesn't make one option universally safer. It means the risk profile must be matched to the patient's anatomy and goals.
Decision point: If the problem is movement, consider a muscle treatment. If it is volume, assess whether filler is appropriate. If it is tissue excess or fat prominence, discuss surgery or noninjectable options.
Patients considering volume restoration can review dermal fillers in Bradenton, FL as one possible pathway, but an under-eye consultation should first determine whether filler is suitable. In some cases, the safest recommendation is skin treatment, observation, or no procedure.
Patient Selection and Contraindications
Patient selection is the strongest safety measure in this area. A technically precise injection can still create a poor outcome if the patient begins with reduced tear production, weak eyelid support, or a structural concern that Botox cannot address.
A consultation should include more than a review of wrinkles. I want to know whether the patient experiences dry, burning, or gritty eyes, uses contact lenses, has had eyelid surgery, or has a history of facial nerve problems. Previous symptoms matter because the treatment may reduce the patient's ability to compensate for an already borderline blink.
Questions that can change the plan
- Eyelid support: Snap-back and distraction testing can reveal laxity that may increase the chance of lower-lid malposition.
- Ocular comfort: Existing dry eye, incomplete closure, or irritation deserves attention before elective periocular treatment.
- Neuromuscular history: A history of Bell's palsy or myasthenia gravis may require particular caution, specialist input, or avoidance.
- Local conditions: An active infection around the eye is a reason to delay treatment until it has resolved.
- Structural anatomy: Dermatochalasis, prominent fat, and pseudoherniation aren't corrected by relaxing muscle and may become more noticeable.
- Medication review: Aminoglycoside antibiotics and other relevant medicines should be discussed with the prescribing clinician and injector.
Expectations are part of candidacy
A patient requesting a dramatic change from a subtle muscle treatment isn't an ideal candidate, even without a medical contraindication. The lower eyelid may have fine lines from skin thinning, sun exposure, dryness, or volume changes, and Botox can address only the component caused by muscle activity.
Recent clinical guidance continues to emphasize ocular adverse events around the eyes, including incomplete blinking, irritation, blurred vision, eyelid drooping, lower-lid swelling, dry eye, pseudo-bags, and ectropion. A recent ophthalmic case series reinforces why baseline eye health should be assessed rather than treated as a footnote.
Managing Expectations and Recovery
The best under-eye Botox result is usually a restrained one. Patients may see softer expression lines, but the treatment won't erase every crease, remove a bag, correct a hollow, or produce the structural change associated with surgery. A consultation should define the specific line being treated and identify the concerns that will remain.
The effect develops gradually rather than appearing immediately. Patients may notice early change within several days, with the result continuing to settle over the following period. A two-week review gives the clinician an opportunity to assess symmetry, eyelid position, blinking, and whether any adjustment is appropriate.
What the appointment feels like
The procedure usually involves brief needle discomfort and may leave pinpoint bruising, tenderness, or localized swelling. Most patients can resume ordinary activities, but the treating clinician's instructions take priority because the lower eyelid is sensitive to rubbing and pressure.
After treatment, patients commonly receive practical precautions such as:
- Protect the area: Don't rub or massage the injection sites unless the injector specifically instructs you to do so.
- Follow positioning advice: Your clinician may advise remaining upright for a period after treatment.
- Modify exercise temporarily: Strenuous activity may need to wait until the recommended recovery window has passed.
- Watch eye symptoms: Report new dryness, inability to close the eye, worsening irritation, blurred vision, diplopia, or a noticeable lid shift.
- Attend follow-up: A review allows the provider to evaluate function, not just photographs.
The treatment also requires a maintenance mindset. As muscle activity returns, dynamic lines can return too, and repeating treatment isn't appropriate unless the eyelids and ocular surface remain healthy. If the first session produces functional symptoms, adding more toxin isn't the answer. The clinician should reassess the diagnosis, the technique, and safer alternatives.
At Aspire for Wellness Together in Bradenton, Florida, aesthetic recommendations are individualized according to medical history, symptoms, medications, anatomy, goals, and provider evaluation. The practice offers neuromodulator and filler consultations, but candidacy for injections around the eyes depends on an in-person assessment rather than a fixed menu choice.
If you're considering Botox injections under the eyes in the Bradenton area, visit Aspire for Wellness Together to request a consultation focused on your eyelid support, eye comfort, facial movement, and treatment goals. The team can help determine whether a conservative neuromodulator approach, another aesthetic option, or no injection is the most appropriate next step.
